bioRxivImmunologyPreprint
Copper Sulfide Nanoparticle-Mediated Photothermolysis Induces Immunogenic Cell Death in Ovarian Cancer Cells
Dan LiiD, Sixiang ShiiD, Qizhen CaoiD, Anil K. SoodiD, Jeffrey J. MolldremiD, Qing MaiD, Chun LiiD
Abstract
Immunotherapy has only limited efficacy against ovarian cancer because of dysfunctional T cells in an immunosuppressive tumor microenvironment. Selective photothermolysis is a technique in which short pulsed laser is used to ablate tissue in targeted regions in a precise spatiotemporally controlled manner. This technique allows targeted tissue ablation without damage to surrounding tissue. In the current study, we demonstrated that ovarian cancer cells treated with photothermolysis mediated by near-infrared-absorbing CuS nanoparticles and 15-ns laser pulses were ingested by human monocyte-derived dendritic cells (MoDCs) more efficiently than were ovarian cancer cells treated with ionizing radiation. Moreover, ingestion of ovarian cancer cells treated with CuS NP-mediated photothermolysis promoted MoDC activation. Immature MoDCs that had been exposed to photothermolysis-treated cancer cells caused greater clonal expansion of co-cultured human CD4+ and CD8+ T cells than did immature MoDCs that had been exposed to ionizing radiation-treated tumor cells. These data indicate that photothermolysis may be used to selectively target and destroy tumor cells and cause them to release antigens and danger signals, which can be recognized by DCs to activate T cells.
- organism: human
- research focus: cancer & tumor microenvironment
- research focus: host-pathogen & immune response
- research focus: cell signaling & trafficking
- approach: experimental assay
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Laser nanobubbles induce immunogenic cell death in breast cancer
H. T. M. Nguyen, N. Katta, … J. W. Tunnell·bioRxiv·Sep 4, 2020
- Nanoparticle mediated delivery of PD-L1 inhibitor enhances γδ T cell immunotherapy against metastatic ovarian cancer cells
Laura O’conner, Jessica Eakins, … Bashir M. Mohamed·bioRxiv·Jun 9, 2026
- In situ generated vaccine-like pyroptosome for personalized cancer immunotherapy
Binlong Chen, Fangjie Wan, … Yiguang Wang·Nature MaterialsPeer-reviewed·Mar 3, 2026
- Isoform switch of CD47 provokes macrophage-mediated pyroptosis in ovarian cancer
Zixiang Wang, Lei Yang, … Zhaojian Liu·bioRxiv·Apr 17, 2025
- Focused Ultrasound Thermal Ablation and CD40 Agonism Reprograms Breast Tumor Immunity to Drive Regression and Memory
Zehra E.F. Demir, AeRyon Kim, … Natasha Sheybani·Journal for ImmunoTherapy of CancerPeer-reviewed·Aug 1, 2026
- A Machine Learning-optimized system for on demand, pulsatile, photo- and chemo-therapeutic treatment using near-infrared responsive MoS2-based microparticles in a breast cancer model
M. Kanelli, N. M. Bardhan, … A. Jaklenec·bioRxiv·Apr 16, 2023